{"id":"gemcitabine-cisplatin-sunitinib","safety":{"commonSideEffects":[{"rate":"30%","effect":"Neutropenia"},{"rate":"20%","effect":"Anemia"},{"rate":"15%","effect":"Thrombocytopenia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Gemcitabine is a chemotherapy medication used to treat various types of cancer. It works by inhibiting DNA synthesis, which ultimately leads to cell death.","oneSentence":"Gemcitabine is a nucleoside analog that inhibits DNA synthesis by inhibiting ribonucleotide reductase.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:37:46.225Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer"},{"name":"Pancreatic cancer"},{"name":"Breast cancer"}]},"trialDetails":[{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT01309633","phase":"PHASE2","title":"Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2011-09-02","conditions":"Nasopharyngeal Carcinoma","enrollment":80},{"nctId":"NCT01089088","phase":"PHASE2","title":"Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)","status":"COMPLETED","sponsor":"Cardiff University","startDate":"2009-04","conditions":"Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer","enrollment":63},{"nctId":"NCT00821327","phase":"PHASE2","title":"Gemzar, Cisp, Sunitinib Urothelial Ca","status":"COMPLETED","sponsor":"US Oncology Research","startDate":"2008-08","conditions":"Urothelial Cancer","enrollment":36},{"nctId":"NCT00705874","phase":"PHASE1","title":"Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma","status":"COMPLETED","sponsor":"Progen Pharmaceuticals","startDate":"2006-05","conditions":"Cancer","enrollment":172},{"nctId":"NCT00859339","phase":"PHASE2","title":"Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC","status":"TERMINATED","sponsor":"Noah Hahn, M.D.","startDate":"2009-03","conditions":"Transitional Cell Carcinoma of the Bladder","enrollment":9},{"nctId":"NCT00847015","phase":"PHASE2","title":"Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2009-02","conditions":"Bladder Cancer, Urinary Bladder","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Gemzar, Sutent"],"phase":"phase_2","status":"active","brandName":"Gemcitabine, Cisplatin, Sunitinib","genericName":"Gemcitabine, Cisplatin, Sunitinib","companyName":"US Oncology Research","companyId":"us-oncology-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Gemcitabine is a nucleoside analog that inhibits DNA synthesis by inhibiting ribonucleotide reductase. Used for Non-small cell lung cancer, Pancreatic cancer, Breast cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}